ERBB2 and breast cancer: These data show a gradual and continuous increase in rat BRCA1-IRIS mRNA expression during breast cancer progression/invasion, which correlates with significant decrease in the expression of rat ERα mRNA and strongly support the notion that BRCA1-IRIS overexpression is involved in breast cancer progression, most likely of the HER2+ and/or TN/BL subtypes.